Neurofunctional Pain Management for Chronic Knee Pain – A 52% Reduction in Pain

Download Now
Learn / Clinical Insights / Knee Pain
Index_NFPM Knee.png

Abstract

Neurofunctional Pain Management, NFPM, a non-pharmaceutical, non-surgical, non-invasive, and non-chiropractic therapy protocol consisting of a combination of electroanalgesia therapy, IV nutritional hydration, and health coaching, has shown to be an effective method of chronic pain treatment for chronic knee pain in participants who completed a normal course of therapy. NFPM was shown to produce a reduction in chronic knee pain by 52%, representing a 4 point drop on a standard 0-10 pain scale. This study shows that NFPM may be an effective treatment option for patients suffering from chronic peripheral neuropathy.

Introduction

Chronic Knee Pain,CKP, is a debilitating pain condition affecting many patients. CKP presents significant challenges for medical providers. There are multiple causes of CKP with one of the most common being that of osteoarthritis. Traditional pharmaceutical therapies are often ineffective, reduce in efficacy over time, and frequently create undesirable side effects and medication interactions. Non-pharmaceutical treatment options for CKP are rare and often do not provide the relief sufficient to impact the patient’s quality of life. Additionally, knee pain increases as the condition remains.

Most pain management providers would define pain relief success with a chronic pain condition to be anything greater than a 30% reduction in pain. According to a study published in The Journal of Pain, a 30% or greater reduction in pain resulted in a pain relief outcome that the patient felt was significantly valid in improving their quality of life. “Changes of approximately 2.0 points or 30% to 36% represent “much better,” “much improved,” or “meaningful” decreases in chronic pain, and a decrease of ≥4 points or ≥50% appears to represent a substantial (“very much improved”) change in pain, 1 which patients have also considered “treatment success”112 or “satisfactory improvement.” (Dworkin et al., 2009)

Neurofunctional Pain Management, NFPM, presents as an impressive alternative to pharmaceutical and conventional pain treatment options. NFPM is a combination of high-frequency high-pulse electroanalgesia electrical currents, which penetrate deep tissues to create neural tissue modulation and sustained depolarization, specialized vitamin/mineral IV hydration, and targeted health coaching to produce effective and lasting pain relief for patients suffering from CKP.

This combination of therapies, which comprises the NFPM protocol, produces a substantial pain relief effect as demonstrated by the study data. Patients engaging in NFPM treatments for Chronic Knee Pain may experience a pain reduction of greater than 50%. This level of pain relief derived through non-pharmaceutical options offers providers an excellent opportunity to help their patients who suffer from debilitating CKP, particularly when pharmaceutical options have proven ineffective, and dosing of various medications poses too great a risk to the patient.

Methods

This study consists of secondary data collected from medical practices conducting a six-week Neurofunctional Pain Management treatment protocol. Patients in this treatment protocol were screened by a qualified medical provider and were issued orders for a treatment program that consisted of two treatment events per week. Each event consisted of a 53 min treatment cycle of electroanalgesia therapy with one of these events including a concurrent one-liter vitamin/mineral blend IV infusion. The patient also received one hour of health coaching each week while in the program. This combination of activities resulted in the pain relief outcomes demonstrated by the results data shown below.

Results

This study consisted of 4 participants with Chronic Knee Pain and revealed that after completing six weeks of NFPM treatment the average pain reduction point drop was 4 on a 0-10 pain scale. This reflects an average 52% pain reduction average for the entire population of the study.

Condition Order Sex Before After
Knee Pain 1 F 7 5
Knee Pain 2 F 7 4
Knee Pain 3 F 7 5
Knee Pain 4 F 10 1
7.75 3.75
Point Drop 4
Percent Drop 0.52

Discussion

These data conclude that Neurofunctional Pain Management may be a significant contribution to the treatment of CKP. Pain score data is collected at each treatment event, making it convenient to identify. A wide range of health improvements and quality of life improvements, as reported by participants as a result of the NFPM treatment program, are improved sleep, reduced stress, improved breathing and even reduced blood pressure. None of these topics were included in this study as data points due to this study being comprised of secondary data with no additional access to records to determine the significance or score of these additional quality of life improvements.

Further research is needed to determine if NFPM should be considered a standardized treatment protocol for CKP generally. Additionally, further research is needed to determine if NFPM should be considered the first line treatment option before prescribing pharmaceutical options or engaging in surgery or interventional procedures. With the efficacy rate shown in this study, and knowing that NFPM is a non-invasive therapy, it is possible that NFPM could be integrated into the medical decision-making process as a required therapy option prior to the allowance of invasive surgery or interventional procedures. The general assumption is that the sooner NFPM is implemented in the degradation of CKP the more successful the long-term results would be at preventing major interventional procedures and surgeries later on.

Considering the side effects and drug interactions prevalent with pharmaceutical options for CKP, and given the non-pharmaceutical nature of NFPM, it is also possible that this therapy option could become the primary standard of care for CKP prior to a prescribed pharmaceutical. More research is needed to establish the feasibility of NFPM as a primary option standard of care before the consideration of a pharmaceutical option.

Conclusion

Neurofunctional Pain Management has shown to be a viable treatment option for patients suffering from Chronic Knee Pain, showing a greater than 50% reduction in chronic pain. NFPM may be able to replace many current conventional therapies for CKP such as pharmaceutical prescriptions, invasive procedures, and risky and expensive surgeries. NFPM may offer patients and medical providers a better first choice treatment option that is non-pharmaceutical, non-surgical, and non-invasive.

References

Bozeman, W. (2023, July 6). Electroanalgesia treatment within neurofunctional pain management. Neuragenex. https://neuragenex.com/modality/electroanalgesia/

Dworkin, R. H., Turk, D. C., McDermott, M. P., Peirce-Sandner, S., Burke, L. B., Cowan, P., Farrar, J. T., Hertz, S., Raja, S. N., Rappaport, B. A., Rauschkolb, C., & Sampaio, C. (2009). Interpreting the clinical importance of group differences in Chronic pain clinical trials: Immpact recommendations. Pain, 146(3), 238–244. https://doi.org/10.1016/j.pain.2009.08.019

Limoge, A., & Stanley, T. (2006). Electroanalgesia, systemic. Encyclopedia of Medical Devices and Instrumentation. https://doi.org/10.1002/0471732877.emd089

Robb, K. A., Newham, D. J., & Williams, J. E. (2007). Transcutaneous electrical nerve stimulation vs. transcutaneous spinal electroanalgesia for chronic pain associated with breast cancer treatments. Journal of Pain and Symptom Management, 33(4), 410–419. https://doi.org/10.1016/j.jpainsymman.2006.09.020

Schwartz, R. G. (1998). Electric sympathetic block: Current theoretical concepts and clinical results. Journal of Back and Musculoskeletal Rehabilitation, 10(1), 31–46. https://doi.org/10.3233/bmr-1998-10105

Wang, S.-M. (2016). Electroanalgesia in pain management. Integrative Pain Management, 469–482. https://doi.org/10.1093/med/9780199315246.003.0033

White, P. F., Elvir Lazo, O. L., Galeas, L., & Cao, X. (2017). Use of Electroanalgesia and Laser Therapies as alternatives to opioids for acute and chronic pain management. F1000Research, 6, 2161. https://doi.org/10.12688/f1000research.12324.1

White, P. F., Li, S., & Chiu, J. W. (2001). Electroanalgesia: Its role in acute and chronic pain management. Anesthesia & Analgesia, 92(2), 505–513. https://doi.org/10.1213/00000539-200102000-00042

will-boseman

About the Author

Will is a healthcare executive, innovator, entrepreneur, inventor, and writer with a wide range of experience in the medical field. Will has multiple degrees in a wide range of subjects that give depth to his capability as an entrepreneur and capacity to operate as an innovative healthcare executive.

Share on Social Media

Found This Useful?

Download the PDF to share with patients and colleagues

Download Now

Other Articles By Will

Neurofunctional Pain Management Shows a 92% success rate in the Treatment of Chronic Peripheral Neuropathy

Neurofunctional Pain Management Shows a 92% success rate in the Treatment of Chronic Peripheral Neuropathy

Read More >>